Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements "TREASURE"

Recruiting

Phase 2/3 Results N/A

Summary of Purpose

The primary objectives of this study is to evaluate the efficacy of HLCM051 on functional outcome in subjects with acute ischemic stroke and to evaluate the safety of HLCM051 in subjects with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 November 2017.

15 Nov 2017 7 Nov 2016 1 Mar 2018 1 Mar 2018 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts